SA PRO
Free Account
GSK plcGSKNYSE
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
29 analysts·High coverage
31%
Rating Distribution
Strong Buy
00%
Buy
931%
Hold
1655%
Sell
414%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 10% higher.

Bear Case
$53.00
+10%
Consensus
$53.00
+10%
Bull Case
$53.00
+10%
Price Range29 analysts
Low
Consensus
High
$53.00
$53.00
Current Target
Current Price
$48.22
Upside to Target
$4.78

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$4.89(6 analysts)
P/E13x
Current: 13.3x
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+4.71%
EPS+8.75%
FY2028
Rev+3.88%
EPS+5.03%
FY2029
Rev+1.73%
EPS+3.62%

Earnings Surprises

Beat rate:92%(11/12 quarters)
Avg surprise:+11.7%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Oct 30, 2025CFRA
CFRA Upgrades GlaxoSmithKline (GSK) to Buy
Target:$53.00
+13.6%from $46.67
Apr 15, 2025BNP Paribas
GSK initiated with a Neutral at BNP Paribas Exane
Target:$35.25
-1.2%from $35.68
Jul 2, 2024Jefferies
GSK price target raised to $53 from $52.50 at Jefferies
Target:$53.00
+38.1%from $38.38
Apr 11, 2024Guggenheim
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
Target:$36.00
-11.5%from $40.69
Apr 11, 2024Morgan Stanley
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
Target:$85.00
+108.9%from $40.69

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance